Tazemetostat for tumors harboring SMARCB1, SMARCA4 or EZH2 alterations: results from NCI-COG Pediatric MATCH

UW Pediatrics first author
Douglas Hawkins
Et. al
and additional authors
Publication Date
PMID
37228094
Journal name
Journal of the National Cancer Institute